Cardioprotection by ischemic postconditioning is abrogated in hypertrophied myocardium of spontaneously hypertensive rats

Journal of Cardiovascular Pharmacology

Volumn 61, Issue 1, 2013, Pages 35-41

  Wagner, Claudia ^a   Ebner, Bernd ^a   Tillack, Diana ^a   Strasser, Ruth H ^a   Weinbrenner, Christof ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

hypertension; hypertrophy; infarction; ischemia; postconditioning

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; HEART HEMODYNAMICS; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; ISCHEMIC POSTCONDITIONING; MALE; MEAN ARTERIAL PRESSURE; MORPHOMETRICS; NONHUMAN; OXYGEN TENSION; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION INJURY; SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR KYOTO RAT;

ANIMALS; CARDIOMEGALY; DISEASE MODELS, ANIMAL; GLYCOGEN SYNTHASE KINASE 3; HEMODYNAMICS; HYPERTENSION; ISCHEMIC POSTCONDITIONING; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; PHOSPHORYLATION; RATS; RATS, INBRED SHR; RATS, INBRED WKY; REPERFUSION INJURY; TIME FACTORS;

EID: 84872295470     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3182760c4d     Document Type: Article

References (38)

1. Reimer KA, Lowe JE, Rasmussen MM, et al. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation. 1977;56:786-794.
2. Braunwald E. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded? Circulation. 1989;79:441-444.
3. Levy D, Anderson KM, Savage DD, et al. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. Ann Intern Med. 1988;108:7-13.
4. Galinanes M, Fowler AG. Role of clinical pathologies in myocardial injury following ischaemia and reperfusion. Cardiovasc Res. 2004;61:512-521.
5. Hearse DJ, Stewart DA, Green DG. Myocardial susceptibility to ischemic damage: a comparative study of disease models in the rat. Eur J Cardiol. 1978;7:437-450.
6. Na HS, Kim YI, Yoon YW, et al. Ventricular premature beat-driven intermittent restoration of coronary blood flow reduces the incidence of reperfusion-induced ventricular fibrillation in a cat model of regional ischemia. Am Heart J. 1996;132:78-83.
7. Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003;285:H579-H588.
8. Staat P, Rioufol G, Piot C, et al. Postconditioning the human heart. Circulation. 2005;112:2143-2148.
9. Hausenloy DJ. Signalling pathways in ischaemic postconditioning. Thromb Haemost. 2009;101:626-634.
10. Juhaszova M, Zorov DB, Yaniv Y, et al. Role of glycogen synthase kinase-3beta in cardioprotection. Circ Res. 2009;104:1240-1252.
11. Hausenloy DJ, Maddock HL, Baxter GF, et al. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res. 2002;55:534-543.
12. Argaud L, Gateau-Roesch O, Raisky O, et al. Postconditioning inhibits mitochondrial permeability transition. Circulation. 2005;111:194-197.
13. Hausenloy DJ, Ong SB, Yellon DM. The mitochondrial permeability transition pore as a target for preconditioning and postconditioning. Basic Res Cardiol. 2009;104:189-202.
14. Penna C, Tullio F, Moro F, et al. Effects of a protocol of ischemic postconditioning and/or captopril in hearts of normotensive and hypertensive rats. Basic Res Cardiol. 2010;105:181-192.
15. Peng LY, Ma H, He JG, et al. Ischemic postconditioning attenuates ischemia/reperfusion injury in isolated hypertrophied rat heart. Zhonghua Xin Xue Guan Bing Za Zhi. 2006;34:685-689.
16. Li XM, Ma YT, Yang YN, et al. Ischemic postconditioning protects hypertrophic myocardium by ERK1/2 signaling pathway: experiment with mice. Zhonghua Yi Xue Za Zhi. 2009;89:846-850.
17. Wagner C, Tillack D, Simonis G, et al. Ischemic post-conditioning reduces infarct size of the in vivo rat heart: role of PI3-K, mTOR, GSK-3beta, and apoptosis. Mol Cell Biochem. 2010;339:135-147.
18. Wagner C, Kloeting I, Strasser RH, et al. Cardioprotection by postconditioning is lost in WOKW rats with metabolic syndrome: role of glycogen synthase kinase 3beta. J Cardiovasc Pharmacol. 2008;52: 430-437.
19. Hönisch A, Theuring N, Ebner B, et al. Postconditioning with levosimendan reduces the infarct size involving the PI3K pathway and KATPchannel activation but is independent of PDE-III inhibition. Basic Res Cardiol. 2010;105:155-167.
20. Friehs I, del Nido PJ. Increased susceptibility of hypertrophied hearts to ischemic injury. Ann Thorac Surg. 2003;75:S678-S684.
21. Gomez L, Paillard M, Thibault H, et al. Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion. Circulation. 2008;117: 2761-2768.
22. Juhaszova M, Zorov DB, Kim SH, et al. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest. 2004;113:1535-1549.
23. Skyschally A, van CP, Iliodromitis EK, et al. Ischemic postconditioning: experimental models and protocol algorithms. Basic Res Cardiol. 2009; 104:469-483.
24. Thibault H, Piot C, Staat P, et al. Long-term benefit of postconditioning. Circulation. 2008;117:1037-1044.
25. Kokubo M, Uemura A, Matsubara T, et al. Noninvasive evaluation of the time course of change in cardiac function in spontaneously hypertensive rats by echocardiography. Hypertens Res. 2005;28:601-609.
26. Cabassi A, Dancelli S, Pattoneri P, et al. Characterization of myocardial hypertrophy in prehypertensive spontaneously hypertensive rats: interaction between adrenergic and nitrosative pathways. J Hypertens. 2007;25: 1719-1730.
27. Diez J. Mechanisms of cardiac fibrosis in hypertension. J Clin Hypertens (Greenwich). 2007;9:546-550.
28. Hausenloy DJ, Tsang A, Yellon DM. Postconditioning does not protect the diabetic heart. J Cell Cardiol Mol. 2006;40:958.
29. Bouhidel O, Pons S, Souktani R, et al. Myocardial ischemic postconditioning against ischemia-reperfusion is impaired in ob/ob mice. Am J Physiol Heart Circ Physiol. 2008;295:H1580-H1586.
30. Friehs I, Stamm C, Cao-Danh H, et al. Insulin-like growth factor-1 improves postischemic recovery in hypertrophied hearts. Ann Thorac Surg. 2001;72:1650-1656.
31. Tsang A, Hausenloy DJ, Mocanu MM, et al. Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res. 2004;95:230-232.
32. Hotchkiss RS, Strasser A, McDunn JE, et al. Cell death. N Engl J Med. 2009;361:1570-1583.
33. Kin H, Wang NP, Mykytenko J, et al. Inhibition of myocardial apoptosis by postconditioning is associated with attenuation of oxidative stressmediated nuclear factor-kappa B translocation and TNF alpha release. Shock. 2008;29:761-768.
34. Cohen MV, Yang XM, Downey JM. Acidosis, oxygen, and interference with mitochondrial permeability transition pore formation in the early minutes of reperfusion are critical to postconditioning's success. Basic Res Cardiol. 2008;103:464-471.
35. Gross ER, Hsu AK, Gross GJ. Delayed cardioprotection afforded by the glycogen synthase kinase 3 inhibitor SB-216763 occurs via a. Am J Physiol Heart Circ Physiol. 2008;294:H1497-H1500.
36. van den BJ, Kovacs P, Kloting I. Metabolic features in disease-resistant as well as in spontaneously hypertensive rats and newly established obese Wistar Ottawa Karlsburg inbred rats. Int J Obes Relat Metab Disord. 2000;24:1618-1622.
37. O'Donnell JM, Fields AD, Sorokina N, et al. The absence of endogenous lipid oxidation in early stage heart failure exposes limits in lipid storage and turnover. J Mol Cell Cardiol. 2008;44:315-322.
38. Heinemann G, Wallrabe D. Determinants of left ventricular hypertrophy in arterial hypertension. Cor Vasa. 1990;32:19-25.